These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impaired insulin secretion and uptake in patients with diffuse idiopathic skeletal hyperostosis. Eckertova M; Krskova K; Penesova A; Radikova Z; Zlnay D; Rovensky J; Zorad S Endocr Regul; 2009 Oct; 43(4):149-55. PubMed ID: 19908933 [TBL] [Abstract][Full Text] [Related]
3. Relationship between diffuse idiopathic skeletal hyperostosis, abdominal aortic calcification and associated metabolic disorders: Data from the Camargo Cohort. Pariente-Rodrigo E; Sgaramella GA; Olmos-Martínez JM; Pini-Valdivieso SF; Landeras-Alvaro R; Hernández-Hernández JL Med Clin (Barc); 2017 Sep; 149(5):196-202. PubMed ID: 28283270 [TBL] [Abstract][Full Text] [Related]
4. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH). Denko CW; Malemud CJ Rheumatol Int; 2006 Feb; 26(4):292-7. PubMed ID: 15703952 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Mader R; Novofestovski I; Adawi M; Lavi I Semin Arthritis Rheum; 2009 Apr; 38(5):361-5. PubMed ID: 18304611 [TBL] [Abstract][Full Text] [Related]
7. Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. Senolt L; Hulejova H; Krystufkova O; Forejtova S; Andres Cerezo L; Gatterova J; Pavelka K; Vencovsky J Ann Rheum Dis; 2012 Jan; 71(1):71-4. PubMed ID: 21900287 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Denko CW; Boja B; Malemud CJ Front Biosci; 2002 Apr; 7():a37-43. PubMed ID: 11897552 [TBL] [Abstract][Full Text] [Related]
9. Adiponectin: possible link between metabolic stress and oxidative stress in the elderly. Gradinaru D; Margina D; Borsa C; Ionescu C; Ilie M; Costache M; Dinischiotu A; Prada GI Aging Clin Exp Res; 2017 Aug; 29(4):621-629. PubMed ID: 27688246 [TBL] [Abstract][Full Text] [Related]
10. A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. Vezyroglou G; Mitropoulos A; Antoniadis C J Rheumatol; 1996 Apr; 23(4):672-6. PubMed ID: 8730125 [TBL] [Abstract][Full Text] [Related]
11. [Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters]. Pavelková A; Pavelka K Vnitr Lek; 2006 May; 52(5):477-80. PubMed ID: 16771094 [TBL] [Abstract][Full Text] [Related]
12. Diffuse idiopathic skeletal hyperostosis: Etiology and clinical relevance. Kuperus JS; Mohamed Hoesein FAA; de Jong PA; Verlaan JJ Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101527. PubMed ID: 32456997 [TBL] [Abstract][Full Text] [Related]
13. The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis. Pappone N; Di Minno MN; Iervolino S; Lupoli R; Mader R; Zincarelli C; Peluso R Rheumatol Int; 2015 Dec; 35(12):2041-6. PubMed ID: 26048625 [TBL] [Abstract][Full Text] [Related]
14. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome. Gupta V; Mishra S; Mishra S; Gupta V Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis. Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease in diffuse idiopathic skeletal hyperostosis (DISH): from theory to reality-a 10-year follow-up study. Glick K; Novofastovski I; Schwartz N; Mader R Arthritis Res Ther; 2020 Aug; 22(1):190. PubMed ID: 32807215 [TBL] [Abstract][Full Text] [Related]